Form 8-K - Current report:
SEC Accession No. 0001390478-18-000003
Filing Date
2018-04-26
Accepted
2018-04-26 16:33:44
Documents
1
Period of Report
2018-04-25
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K sls-20180426x8xkspecialmee.htm 8-K 39395
  Complete submission text file 0001390478-18-000003.txt   40790
Mailing Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017
Business Address 315 MADISON AVENUE 4TH FLOOR NEW YORK NY 10017 (813) 864-4523
SELLAS Life Sciences Group, Inc. (Filer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33958 | Film No.: 18779059
SIC: 2834 Pharmaceutical Preparations